157 related articles for article (PubMed ID: 20392246)
1. Heritable sclerosing bone disorders: presentation and new molecular mechanisms.
de Vernejoul MC; Kornak U
Ann N Y Acad Sci; 2010 Mar; 1192():269-77. PubMed ID: 20392246
[TBL] [Abstract][Full Text] [Related]
2. Sclerosing bone disorders.
de Vernejoul MC
Best Pract Res Clin Rheumatol; 2008 Mar; 22(1):71-83. PubMed ID: 18328982
[TBL] [Abstract][Full Text] [Related]
3. [Genetic basis for skeletal disease. Molecular advances in sclerosing bone disorders].
Michigami T
Clin Calcium; 2010 Aug; 20(8):1196-202. PubMed ID: 20675930
[TBL] [Abstract][Full Text] [Related]
4. Human osteopetrosis and other sclerosing disorders: recent genetic developments.
de Vernejoul MC; Bénichou O
Calcif Tissue Int; 2001 Jul; 69(1):1-6. PubMed ID: 11685426
[TBL] [Abstract][Full Text] [Related]
5. Osteoclast diseases.
Helfrich MH
Microsc Res Tech; 2003 Aug; 61(6):514-32. PubMed ID: 12879419
[TBL] [Abstract][Full Text] [Related]
6. Recent progress in the molecular genetics of sclerosing bone dysplasias.
Van Hul W
Pediatr Pathol Mol Med; 2003; 22(1):11-22. PubMed ID: 12687886
[TBL] [Abstract][Full Text] [Related]
7. Are nonresorbing osteoclasts sources of bone anabolic activity?
Karsdal MA; Martin TJ; Bollerslev J; Christiansen C; Henriksen K
J Bone Miner Res; 2007 Apr; 22(4):487-94. PubMed ID: 17227224
[TBL] [Abstract][Full Text] [Related]
8. A clinical and molecular overview of the human osteopetroses.
Balemans W; Van Wesenbeeck L; Van Hul W
Calcif Tissue Int; 2005 Nov; 77(5):263-74. PubMed ID: 16307387
[TBL] [Abstract][Full Text] [Related]
9. Osteoclast biology: lessons from mammalian mutations.
Marks SC
Am J Med Genet; 1989 Sep; 34(1):43-54. PubMed ID: 2683780
[TBL] [Abstract][Full Text] [Related]
10. SOST/sclerostin, an osteocyte-derived negative regulator of bone formation.
van Bezooijen RL; ten Dijke P; Papapoulos SE; Löwik CW
Cytokine Growth Factor Rev; 2005 Jun; 16(3):319-27. PubMed ID: 15869900
[TBL] [Abstract][Full Text] [Related]
11. Sclerosing bone dysplasias: review and differentiation from other causes of osteosclerosis.
Ihde LL; Forrester DM; Gottsegen CJ; Masih S; Patel DB; Vachon LA; White EA; Matcuk GR
Radiographics; 2011; 31(7):1865-82. PubMed ID: 22084176
[TBL] [Abstract][Full Text] [Related]
12. A Review of the Clinical, Radiological and Biochemical Characteristics and Genetic Causes of High Bone Mass Disorders.
Chen X; Yu H; Yu X
Curr Drug Targets; 2018; 19(6):621-635. PubMed ID: 29359663
[TBL] [Abstract][Full Text] [Related]
13. Human Genetics of Sclerosing Bone Disorders.
De Ridder R; Boudin E; Mortier G; Van Hul W
Curr Osteoporos Rep; 2018 Jun; 16(3):256-268. PubMed ID: 29656376
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms by which cells of the osteoblast lineage control osteoclast formation and activity.
Martin TJ; Ng KW
J Cell Biochem; 1994 Nov; 56(3):357-66. PubMed ID: 7876329
[TBL] [Abstract][Full Text] [Related]
15. Severe developmental bone phenotype in ClC-7 deficient mice.
Neutzsky-Wulff AV; Sims NA; Supanchart C; Kornak U; Felsenberg D; Poulton IJ; Martin TJ; Karsdal MA; Henriksen K
Dev Biol; 2010 Aug; 344(2):1001-10. PubMed ID: 20599900
[TBL] [Abstract][Full Text] [Related]
16. Identification of the disease-causing gene in sclerosteosis--discovery of a novel bone anabolic target?
Balemans W; Van Hul W
J Musculoskelet Neuronal Interact; 2004 Jun; 4(2):139-42. PubMed ID: 15615113
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of osteoclast mediated bone resorption--rationale for the design of new therapeutics.
Väänänen K
Adv Drug Deliv Rev; 2005 May; 57(7):959-71. PubMed ID: 15876398
[TBL] [Abstract][Full Text] [Related]
18. [Regulation of osteoclast activity: a new approach in the therapy of bone diseases].
Vanhara P; Smarda J
Cas Lek Cesk; 2006; 145(8):606-10. PubMed ID: 16995415
[TBL] [Abstract][Full Text] [Related]
19. Mixed-sclerosing-bone-dystrophy: 42-year follow-up of a case reported as osteopetrosis.
Pacifici R; Murphy WA; Teitelbaum SL; Whyte MP
Calcif Tissue Int; 1986 Mar; 38(3):175-85. PubMed ID: 3085895
[TBL] [Abstract][Full Text] [Related]
20. Role of CSF-1 in bone and bone marrow development.
Cecchini MG; Hofstetter W; Halasy J; Wetterwald A; Felix R
Mol Reprod Dev; 1997 Jan; 46(1):75-83; discussion 83-4. PubMed ID: 8981367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
